Revolution Medicines Cash from Financing (TTM) Trends

Revolution Medicines Inc (RVMD)

40.20 +1.01 (+2.58%) USD | NASDAQ | May 03, 16:00

40.20 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	1.229B
September 30, 2023	441.21M
June 30, 2023	688.53M
March 31, 2023	625.33M
December 31, 2022	301.43M
September 30, 2022	260.80M
June 30, 2022	12.78M
March 31, 2022	12.22M
December 31, 2021	294.18M

Date	Value
September 30, 2021	284.94M
June 30, 2021	453.50M
March 31, 2021	451.30M
December 31, 2020	422.78M
September 30, 2020	419.76M
June 30, 2020	260.88M
March 31, 2020	352.39M
December 31, 2019	98.66M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

12.22M

Minimum

Mar 2022

1.229B

Maximum

Dec 2023

388.82M

Average

352.39M

Median

Mar 2020

Cash from Financing (TTM) Benchmarks